Related by context. Frequent words. (Click for all words.) 66 Receives Orphan Drug Designation 65 Application MAA 65 R sorafenib tablets 65 Kuvan R 64 addressing idiopathic pulmonary 64 submitted Marketing Authorization 64 Pirfenidone 64 Initiates Phase II 63 fibrosis IPF 63 Orphan Drug status 63 produces Chrysler Jeep 63 FDA Accepts 63 Marketing Authorisation 63 orphan medicinal product 63 Positive Opinion 62 orphan designation 62 submitted Biologics License 62 NASDAQ CRXL 62 Orphan Drug designation 62 Angiox 62 FIRAZYR 62 Aloxi R 62 ZALBIN 61 NASDAQ OSIR 61 Loramyc R 61 Alferon N Injection 61 refractory chronic lymphocytic 61 Rebif ® 61 ATryn ® 61 Presents Positive 61 Marketing Authorization Application MAA 60 Belimumab 60 NASDAQ SHPGY 60 supplemental Biologics License Application 60 Marketing Authorization 60 Ranexa R 60 Panzem R 60 Icatibant 60 Meets Primary Endpoint 60 Nexavar ® 60 Plenaxis R 60 C1 esterase inhibitor 60 Rotarix R 59 Marketing Authorization Application 59 Eloxatin ® 59 Orphan Medicinal Product 59 THALOMID 59 Nasdaq VRTX 59 Azilect ® 59 Amrubicin 59 Alitretinoin 59 Medicinal Products EMEA 59 eprodisate KIACTA TM 59 SCHWARZ PHARMA 59 Clofarabine 58 Ixempra 58 Application BLA 58 diabetic peripheral neuropathic pain 58 ABILIFY R 58 Ambrisentan 58 relapsing forms 58 topical anti infective 58 Onalta 58 rilonacept 58 Completes Enrollment 58 post herpetic neuralgia PHN 58 Patent Covering 58 Files Shelf Registration Statement 58 granted Orphan Drug 58 Junovan 58 human antithrombin 57 Daclizumab 57 APPROVAL OF 57 DRRX 57 GlaxoSmithKline plc GSK 57 Focetria 57 hepatitis B HBV 57 OTCQX RHHBY 57 TELINTRA 57 proteasome inhibitor 57 THELIN 57 Regains Compliance 57 FDA Orphan Drug 57 Orphan Drug Status 57 Clinical Trial Application 57 Pivotal Phase III 57 Hexvix 57 Xyntha 57 Argatroban 56 Aclasta 56 Mutual Recognition Procedure 56 SmarTrend Biotechnology 56 Injectable Suspension 56 candidates bavituximab 56 NASDAQ IMCL 56 castrate resistant prostate cancer 56 Masimo NASDAQ MASI 56 Lubiprostone 56 Soliris TM eculizumab 56 undergoing coronary angioplasty 56 PRIALT